Our study has shown high concentrations of CCL1 and CCL8 in the CSF of WNND and TBE patients and identified CXCL5 as a possible biomarker that allows the classification of patients as having WNDD or TBE. This evidence concerns the gene CCL8 and tick-borne encephalitis.